A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN Study)
Latest Information Update: 09 May 2023
At a glance
- Drugs Elexacaftor/ivacaftor/tezacaftor (Primary) ; Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Acronyms BEGIN
- 04 May 2023 Status changed from active, no longer recruiting to recruiting.
- 02 Feb 2022 Status changed from recruiting to active, no longer recruiting.
- 23 Nov 2020 Planned End Date changed from 30 Jun 2024 to 1 Oct 2025.